换一批
换一批A Model for Decoding Resistance in Precision Oncology: Acquired Resistance to FGFR inhibitors in Cholangiocarcinoma.
作者：
L,Goyal [1]
;
D,DiToro [2]
;
F,Facchinetti [3]
;
E E,Martin [4]
;
P,Peng [5]
;
I,Baiev [6]
;
R,Iyer [7]
;
J,Maurer [6]
;
S,Reyes [6]
;
K,Zhang [8]
;
U,Majeed [9]
;
J E,Berchuck [10]
;
C T,Chen [11]
;
C,Walmsley [6]
;
C,Pinto [6]
;
D,Vasseur [3]
;
J D,Gordan [8]
;
K,Mody [9]
;
M,Borad [12]
;
T,Karasic [13]
;
N,Damjanov [13]
;
B P,Danysh [4]
;
E,Wehrenberg-Klee [14]
;
A R,Kambadakone [14]
;
S K,Saha [15]
;
I D,Hoffman [16]
;
K J,Nelson [16]
;
S,Iyer [16]
;
X,Qiang [5]
;
C,Sun [5]
;
H,Wang [5]
;
L,Li [5]
;
M,Javle [17]
;
B,Lin [18]
;
W,Harris [19]
;
A X,Zhu [6]
;
J M,Cleary [10]
;
K T,Flaherty [6]
;
T,Harris [16]
;
R T,Shroff [20]
;
I,Leshchiner [4]
;
L,Parida [21]
;
R K,Kelley [8]
;
J,Fan [22]
;
J R,Stone [2]
;
N V,Uboha [23]
;
H,Hirai [24]
;
H,Sootome [24]
;
F,Wu [5]
;
D C,Bensen [16]
;
A,Hollebecque [3]
;
L,Friboulet [3]
;
J K,Lennerz [6]
;
G,Getz [25]
;
D,Juric [6]
作者单位：
Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA; Department of Medicine, Stanford Cancer Center, Stanford University School of Medicine, Palo Alto, CA. Electronic address: lgoyal@stanford.edu.
[1]
Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
[2]
Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.
[3]
Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
[4]
TransThera Sciences (Nanjing), Inc., Nanjing, China.
[5]
Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
[6]
Department of Medical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
[7]
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.
[8]
Division of Hematology/Oncology, Mayo Clinic, Jacksonville, FL.
[9]
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
[10]
Department of Medicine, Stanford Cancer Center, Stanford University School of Medicine, Palo Alto, CA.
[11]
Division of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ.
[12]
University of Pennsylvania Abramson Cancer Center, Philadelphia, PA.
[13]
Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
[14]
Human Biology Division, Fred Hutchinson Cancer Center, Seattle, Washington.
[15]
Tyra Biosciences, San Diego, CA.
[16]
MD Anderson Cancer Center, Houston, TX.
[17]
Virginia Mason Medical Center, Seattle, WA.
[18]
University of Washington/Fred Hutchinson Cancer Center, Seattle, WA.
[19]
University of Arizona Cancer Center, University of Arizona, Tucson, AZ.
[20]
IBM Research, Yorktown Heights, NY, USA.
[21]
TransThera Sciences, (US), Inc., Gaithersburg, MD.
[22]
University of Wisconsin Carbone Cancer Center, Madison, WI.
[23]
Tsukuba Research Institute, Taiho Pharmaceutical Co., Ltd., Japan.
[24]
Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
[25]
DOI
10.1016/j.annonc.2024.12.011
PMID
39706336
发布时间
2024-12-20
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
